FILGRASTIM — all Canadian products
13 DINs
13 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is FILGRASTIM, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02556537 | FILRA | JAMP PHARMA CORPORATION | Solution | Intravenous; Subcutaneous | FILGRASTIM 300 MCG | Marketed | |
| 02556545 | FILRA | JAMP PHARMA CORPORATION | Solution | Subcutaneous; Intravenous | FILGRASTIM 480 MCG | Marketed | |
| 02441489 | GRASTOFIL | APOTEX INC | Solution | Intravenous; Subcutaneous | FILGRASTIM 300 MCG | Marketed | |
| 02454548 | GRASTOFIL | APOTEX INC | Solution | Intravenous; Subcutaneous | FILGRASTIM 480 MCG | Marketed | |
| 01968017 | NEUPOGEN | AMGEN CANADA INC | Solution | Subcutaneous; Intravenous | FILGRASTIM 300 MCG | Marketed | |
| 02420104 | NEUPOGEN | AMGEN CANADA INC | Solution | Subcutaneous; Intravenous | FILGRASTIM 600 MCG | Marketed | |
| 02420112 | NEUPOGEN | AMGEN CANADA INC | Solution | Subcutaneous; Intravenous | FILGRASTIM 600 MCG | Marketed | |
| 02485583 | NIVESTYM | PFIZER CANADA ULC | Solution | Intravenous; Subcutaneous | FILGRASTIM 480 MCG | Marketed | |
| 02485591 | NIVESTYM | PFIZER CANADA ULC | Solution | Intravenous; Subcutaneous | FILGRASTIM 300 MCG | Marketed | |
| 02485575 | NIVESTYM | PFIZER CANADA ULC | Solution | Subcutaneous; Intravenous | FILGRASTIM 300 MCG | Marketed | |
| 02485656 | NIVESTYM | PFIZER CANADA ULC | Solution | Intravenous; Subcutaneous | FILGRASTIM 480 MCG | Marketed | |
| 02520990 | NYPOZI | TANVEX BIOPHARMA USA, INC. | Solution | Intravenous; Subcutaneous | FILGRASTIM 300 MCG | Marketed | |
| 02521008 | NYPOZI | TANVEX BIOPHARMA USA, INC. | Solution | Intravenous; Subcutaneous | FILGRASTIM 480 MCG | Marketed |
Browse other molecules: